Key result
4D Flow improves clinical management in adult congenital heart disease by providing advanced hemodynamic markers.
Why the study?
4-dimensional phase-contrast flow measurement has increasing clinical and scientific potential in congenital heart disease, prompting an up-to-date review of its benefits in adults with congenital heart disease.
Does 4D Flow imaging improve hemodynamic assessment and clinical management in adults with congenital heart disease?
Does 4D Flow imaging improve hemodynamic assessment and clinical management in adults with congenital heart disease?
4D Flow imaging is increasingly utilized in clinical practice and research to assess morphological and hemodynamic consequences in adult congenital heart disease, aiding in personalized management.
4D Flow supports routine ACHD flow assessment; leaves open prospective outcome validation before broader practice change.
Purpose of Review 4-dimensional phase-contrast flow measurement (4D Flow) has an increasing clinical and scientific potential in patients with congenital heart disease (CHD). In this review, we present up-to-date information about the benefits of 4D Flow in adults with CHD (ACHD). Recent Findings Due to sequence and software developments 4D is now routinely used for clinical blood flow measurements in ACHD patients. An increasing number of studies also shows that 4D Flow-derived advanced hemodynamic markers cannot only explain cardiovascular conditions but that they can help in ACHD management. Moreover, with the use of computational fluid dynamics and deep learning techniques 4D Flow might help in exploring and developing personalized medical treatment strategies. Summary Utilization of 4D Flow has become widely spread in research as well as in clinical practice allowing to explore morphological and hemodynamical consequences in ACHD.
No takes yet. Share an insight, caveat, or question.
Voges et al. (2024) conducted a review in Adult Congenital Heart Disease. 4-dimensional phase-contrast flow measurement (4D Flow) was evaluated. 4-dimensional phase-contrast flow measurement (4D Flow) provides advanced hemodynamic markers that improve the understanding of pathophysiology and clinical management in adults with congenital heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: